• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B.补体因子B常见多态性赋予年龄相关性黄斑变性保护作用的功能基础。
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4366-71. doi: 10.1073/pnas.0812584106. Epub 2009 Mar 2.
2
Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.常见的 C3、因子 B 和因子 H 多态性共同决定了系统性补体活性和疾病风险。
Proc Natl Acad Sci U S A. 2011 May 24;108(21):8761-6. doi: 10.1073/pnas.1019338108. Epub 2011 May 9.
3
Complement factor B polymorphism 32W protects against age-related macular degeneration.补体因子B多态性32W可预防年龄相关性黄斑变性。
Mol Vis. 2011 Apr 20;17:983-8.
4
Functional Evaluation of AMD-Associated Risk Variants of Complement Factor B.AMD 相关补体因子 B 风险变异的功能评估。
Invest Ophthalmol Vis Sci. 2020 May 11;61(5):19. doi: 10.1167/iovs.61.5.19.
5
Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?非典型溶血性尿毒症综合征中补体因子B突变——与疾病相关还是良性?
J Am Soc Nephrol. 2014 Sep;25(9):2053-65. doi: 10.1681/ASN.2013070796. Epub 2014 Mar 20.
6
The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity.具有疾病保护作用的补体因子H同种异型变体Ile62对C3b的结合亲和力增加,辅助因子活性增强。
Hum Mol Genet. 2009 Sep 15;18(18):3452-61. doi: 10.1093/hmg/ddp289. Epub 2009 Jun 23.
7
A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease models.一种新型抗人补体因子B抗体,可阻断C3bB前转化酶的形成并在疾病模型中抑制补体激活。
J Immunol. 2014 Dec 1;193(11):5567-75. doi: 10.4049/jimmunol.1402013. Epub 2014 Oct 29.
8
Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact.替代补体途径激活片段Ba与C3b结合。有证据表明B因子-C3b复合物的形成涉及两个离散的接触点。
J Biol Chem. 1987 Feb 5;262(4):1519-25.
9
3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.C3bB复合物的三维结构为补体替代途径转化酶的激活和调节提供了见解。
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):882-7. doi: 10.1073/pnas.0810860106. Epub 2009 Jan 9.
10
Ionic tethering contributes to the conformational stability and function of complement C3b.离子连接有助于补体C3b的构象稳定性和功能。
Mol Immunol. 2017 May;85:137-147. doi: 10.1016/j.molimm.2016.12.015. Epub 2017 Mar 8.

引用本文的文献

1
Factor B as a therapeutic target for the treatment of complement-mediated diseases.作为补体介导疾病治疗靶点的B因子
Front Immunol. 2025 Feb 14;16:1537974. doi: 10.3389/fimmu.2025.1537974. eCollection 2025.
2
The role of the complement system in Shiga toxin-associated hemolytic uremic syndrome.补体系统在志贺毒素相关溶血尿毒综合征中的作用。
Pediatr Nephrol. 2025 May;40(5):1711-1722. doi: 10.1007/s00467-024-06629-6. Epub 2025 Jan 10.
3
Complement regulation in the eye: implications for age-related macular degeneration.补体调控与年龄相关性黄斑变性。
J Clin Invest. 2024 May 1;134(9):e178296. doi: 10.1172/JCI178296.
4
Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection.对 COVID-19 患者进行靶向基因分型揭示了与严重感染相关的补体 C3 和因子 B 编码 SNP 的特征。
Immunobiology. 2023 Mar;228(2):152351. doi: 10.1016/j.imbio.2023.152351. Epub 2023 Feb 15.
5
C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration.C1q与年龄相关性黄斑变性继发地图样萎缩中的经典补体级联反应
Int J Retina Vitreous. 2022 Nov 8;8(1):79. doi: 10.1186/s40942-022-00431-y.
6
Functional variant rs12614 in confers a low risk of IgA nephropathy by attenuating complement alternative pathway activation in Han Chinese.功能性变体 rs12614 降低了汉族人群中 IgA 肾病的发病风险,其机制可能是减弱补体替代途径的激活。
Front Immunol. 2022 Oct 13;13:973169. doi: 10.3389/fimmu.2022.973169. eCollection 2022.
7
Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases.遗传变异性塑造了替代途径补体活性和补体相关疾病的易感性。
Immunol Rev. 2023 Jan;313(1):71-90. doi: 10.1111/imr.13131. Epub 2022 Sep 11.
8
Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection.对儿童多系统炎症综合征患者进行靶向基因分型揭示了新冠病毒感染期间补体失调介导的潜在替代途径。
Curr Issues Mol Biol. 2022 Jun 28;44(7):2811-2824. doi: 10.3390/cimb44070193.
9
Complement Factor B Mediates Ocular Angiogenesis through Regulating the VEGF Signaling Pathway.补体因子 B 通过调节 VEGF 信号通路介导眼部血管生成。
Int J Mol Sci. 2021 Sep 3;22(17):9580. doi: 10.3390/ijms22179580.
10
Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option.补体抑制剂在年龄相关性黄斑变性中的应用:一种潜在的治疗选择。
J Immunol Res. 2021 Jul 29;2021:9945725. doi: 10.1155/2021/9945725. eCollection 2021.

本文引用的文献

1
Complement factor H binds to denatured rather than to native pentameric C-reactive protein.补体因子H与变性的而非天然的五聚体C反应蛋白结合。
J Biol Chem. 2008 Nov 7;283(45):30451-60. doi: 10.1074/jbc.M803648200. Epub 2008 Sep 11.
2
The spectrum of complement alternative pathway-mediated diseases.补体替代途径介导的疾病谱。
Immunol Rev. 2008 Jun;223:300-16. doi: 10.1111/j.1600-065X.2008.00641.x.
3
Systemic complement activation in age-related macular degeneration.年龄相关性黄斑变性中的全身补体激活
PLoS One. 2008 Jul 2;3(7):e2593. doi: 10.1371/journal.pone.0002593.
4
Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA.年龄相关性黄斑变性与不稳定的ARMS2(LOC387715)信使核糖核酸相关。
Nat Genet. 2008 Jul;40(7):892-6. doi: 10.1038/ng.170. Epub 2008 May 30.
5
C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes.年龄相关性黄斑病变中的C2和CFB基因以及它们与CFH和LOC387715基因的联合作用。
PLoS One. 2008 May 21;3(5):e2199. doi: 10.1371/journal.pone.0002199.
6
Oxidative damage-induced inflammation initiates age-related macular degeneration.氧化损伤诱导的炎症引发年龄相关性黄斑变性。
Nat Med. 2008 Feb;14(2):194-8. doi: 10.1038/nm1709. Epub 2008 Jan 27.
7
Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration.年龄相关性黄斑变性中CFHR3和CFHR1基因的缺失
Hum Mol Genet. 2008 Apr 1;17(7):971-7. doi: 10.1093/hmg/ddm369. Epub 2007 Dec 15.
8
Complement C3 variant and the risk of age-related macular degeneration.补体C3变体与年龄相关性黄斑变性的风险
N Engl J Med. 2007 Aug 9;357(6):553-61. doi: 10.1056/NEJMoa072618. Epub 2007 Jul 18.
9
Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration.补体因子B和补体成分2变体在年龄相关性黄斑变性中的保护作用。
Hum Mol Genet. 2007 Aug 15;16(16):1986-92. doi: 10.1093/hmg/ddm146. Epub 2007 Jun 18.
10
Estimation of systemic complement C3 activity in age-related macular degeneration.年龄相关性黄斑变性中全身补体C3活性的评估。
Arch Ophthalmol. 2007 Apr;125(4):515-9. doi: 10.1001/archopht.125.4.515.

补体因子B常见多态性赋予年龄相关性黄斑变性保护作用的功能基础。

Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B.

作者信息

Montes Tamara, Tortajada Agustín, Morgan B Paul, Rodríguez de Córdoba Santiago, Harris Claire L

机构信息

Consejo Superior de Investigaciones Cientificas, Centro de Investigación Biomédica en Red de Enfermedades Raras and Fundación Renal Iñigo Alvarez de Toledo, Ramiro de Maeztu 9, 28040 Madrid, Spain.

出版信息

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4366-71. doi: 10.1073/pnas.0812584106. Epub 2009 Mar 2.

DOI:10.1073/pnas.0812584106
PMID:19255449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2657369/
Abstract

Mutations and polymorphisms in complement genes have been linked with numerous rare and prevalent disorders, implicating dysregulation of complement in pathogenesis. The 3 common alleles of factor B (fB) encode Arg (fB(32R)), Gln (fB(32Q)), or Trp (fB(32W)) at position 32 in the Ba domain. The fB(32Q) allele is protective for age-related macular degeneration, the commonest cause of blindness in developed countries. Factor B variants were purified from plasma of homozygous individuals and were tested in hemolysis assays. The protective variant fB(32Q) had decreased activity compared with fB(32R). Biacore comparison revealed markedly different proenzyme formation; fB(32R) bound C3b with 4-fold higher affinity, and formation of activated convertase was enhanced. Binding and functional differences were confirmed with recombinant fB(32R) and fB(32Q); an intermediate affinity was revealed for fB(32W). To confirm contribution of Ba to binding, affinity of Ba for C3b was determined. Ba-fB(32R) had 3-fold higher affinity compared with Ba-fB(32Q). We demonstrate that the disease-protective effect of fB(32Q) is consequent on decreased potential to form convertase and amplify complement activation. Knowledge of the functional consequences of polymorphisms in complement activators and regulators will aid disease prediction and inform targeting of diagnostics and therapeutics.

摘要

补体基因的突变和多态性与众多罕见和常见疾病有关,这表明补体失调在发病机制中起作用。因子B(fB)的3种常见等位基因在Ba结构域的第32位编码精氨酸(fB(32R))、谷氨酰胺(fB(32Q))或色氨酸(fB(32W))。fB(32Q)等位基因对年龄相关性黄斑变性具有保护作用,年龄相关性黄斑变性是发达国家最常见的失明原因。从纯合个体的血浆中纯化出因子B变体,并在溶血试验中进行检测。与fB(32R)相比,具有保护作用的变体fB(32Q)活性降低。表面等离子体共振技术比较显示,酶原形成明显不同;fB(32R)与C3b的结合亲和力高4倍,活化转化酶的形成增强。重组fB(32R)和fB(32Q)证实了结合和功能差异;fB(32W)显示出中等亲和力。为了确认Ba对结合的贡献,测定了Ba与C3b的亲和力。与Ba-fB(32Q)相比,Ba-fB(32R)的亲和力高3倍。我们证明,fB(32Q)的疾病保护作用是由于形成转化酶和放大补体激活的潜力降低所致。了解补体激活剂和调节剂多态性的功能后果将有助于疾病预测,并为诊断和治疗的靶向提供信息。